Unexpectedly Weak Anti-B in 2 Group O Pediatric Patients on Parenteral Nutrition and Disease Specific Supplemental Enteral Feeds

Lab Med. 2020 May 6;51(3):296-300. doi: 10.1093/labmed/lmz057.

Abstract

Anti-A and anti-B antibodies are naturally occurring and develop from exposure to intestinal bacteria after age 4 to 6 months. In the laboratory, strong agglutination with A1 and B cells, or B cells only and A1 cells only, on reverse typing in a healthy person with immunocompetence is expected for patients with ABO types O, A, and B, respectively. However, absent or weak anti-A and anti-B antibodies can be observed in some clinical scenarios, such as patients with immunodeficiencies, newborns, elderly patients, and patients who have recently received bone marrow transplants. In this article, we report the cases of 2 pediatric patients with group O blood type who were receiving total parenteral nutrition (TPN) and disease-specific enteral feeds and who have strong anti-A and absent/weak anti-B.

Keywords: ABO discrepancy; absent/weak anti-B; gut microbiota; total parenteral nutrition (TPN).

Publication types

  • Case Reports

MeSH terms

  • ABO Blood-Group System / immunology*
  • Antibodies / blood
  • Child
  • Child, Preschool
  • Enteral Nutrition / methods*
  • Female
  • Gastroschisis / diagnosis*
  • Gastroschisis / immunology
  • Humans
  • Infant
  • Male
  • Parenteral Nutrition / methods*
  • Urea Cycle Disorders, Inborn / diagnosis*
  • Urea Cycle Disorders, Inborn / immunology

Substances

  • ABO Blood-Group System
  • Antibodies